Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

Understanding Treatment Options for ER+/HER2–, ESR1-Mutant Metastatic Breast Cancer

July 24th 2025, 7:37pm

Video

In this on-demand webinar series, Dr. Igor Makhlin discusses personalized treatment options for ER-positive, HER2-negative metastatic breast cancer, including the role of ESR1 mutation testing and targeted therapies like Orserdu.

New System May Help Keep High-Risk Cancer Patients Out of Hospital

July 22nd 2025, 8:00pm

Article

A system that alerts doctors when high-risk cancer patients are admitted helped reduce hospital readmissions and shorten hospital stays in a recent study.

IV Complications and the Challenge of Being Heard

July 21st 2025, 5:00pm

Article

IV infiltration and extravasation remind this cancer patient of the constant challenges of speaking up and advocating for their own care.

Why I Don’t Call Myself a Survivor With Metastatic Breast Cancer

June 19th 2025, 5:00pm

Article

Living with metastatic breast cancer, I find it hard to relate to the term “survivor.”

Trodelvy/Keytruda Extends PFS Versus Chemo/Keytruda in PD -L1+ TNBC

May 31st 2025, 12:10pm

Article

Trodelvy plus Keytruda, when given in the frontline, extended survival without progression versus chemo plus Keytruda in PD-L1+ metastatic TNBC.

Leronlimab Linked to Increased PD-L1 in Triple-Negative Breast Cancer

May 16th 2025, 2:41pm

Article

Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.

When a Thoughtless Mammogram Reminder Reopened a Deep Cancer Wound

May 10th 2025, 6:00pm

Article

A thoughtless birthday mammogram reminder underscored how the healthcare system ignored my reality of living with metastatic breast cancer.

FDA Completes Review of Hepzato Combo in HER2– Metastatic Breast Cancer

April 30th 2025, 9:00pm

Article

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant metastatic breast cancer.

My 11-Year Metastatic Breast Cancer Story Defied the Standard Path

April 21st 2025, 5:00pm

Article

Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Bria-IMT Combo Outperforms Other Metastatic Breast Cancer Treatments

April 16th 2025, 4:00pm

Article

Bria-IMT plus check point inhibitors had a median overall survival which outperformed that of antibody-drug conjugates in HR+ metastatic breast cancer.